<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ871202-0165 </DOCNO><HL> Baxter Travenol Laboratories</HL><DD> 12/02/87</DD><SO> WALL STREET JOURNAL (J)</SO><IN> BAXBOND MARKET NEWS (BON) </IN><DATELINE> DEERFIELD, Ill.  </DATELINE><TEXT>   Baxter Travenol Laboratories Inc. said it is offering $100 million of its 9 5/8% notes, due Dec. 1, 1994, priced at 99.8%.    The medical products and services concern said the proceeds from the sale will be used to repay existing bank debt. Goldman, Sachs andamp; Co. is the lead underwriter. </TEXT></DOC>